Skip to search formSkip to main contentSkip to account menu

Roxithromycin

Known as: (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-d-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxyimino)-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecan-2-one, RXM, Roxithromycin [Chemical/Ingredient] 
Semisynthetic derivative of erythromycin. It is concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Background and objective:  To examine the effect of a 14‐membered ring macrolide on airway mucus hypersecretion in rats treated… 
Highly Cited
1998
Highly Cited
1998
In view of the action of newer macrolide antibiotics on intracellular protozoa, we have investigated the efficacy of… 
Highly Cited
1992
Highly Cited
1992
A new semisynthetic macrolide roxithromycin was evaluated for its potential use in the treatment of Lyme borreliosis. Using a… 
Highly Cited
1991
Highly Cited
1991
The diffusion of clarithromycin and roxithromycin into respiratory tract tissues was studied in 174 adult patients undergoing… 
Highly Cited
1988
Highly Cited
1988
The in vitro activity of azithromycin (CP 62,993 or XZ-450) against Haemophilus influenzae was greater than that of three other…